Jacques Lespérance - Concepedia

Author

Jacques Lespérance

Also Known As

J L'Espérance, J LESPERANCE, J Lesperance, J Lespèrance, J Lespérance, J L’Esperance, J. J. Lesperance, J. LESPÉRANCE, J. Lesperance, J. Lespérance

239

Publications

13.8K

Citations

H-Index

Concepts

All Affiliations

Montreal Heart Institute Université de Montréal Esperance Hospital

About

Jacques Lespérance is an author at Montreal Heart Institute specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	52	94	8.8K
2	Public Health	34	45	4.6K
3	Health Sciences	10	10	871
4	Engineering	3	3	47
5	Biomedical Engineering	3	3	121

Jacques Lespérance

127

Publications

13K

Citations

H-Index

Page 1

	Year	Citations
Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty Leonard Schwartz, Martial G. Bourassa, Jacques Lespérance, New England Journal of Medicine Endovascular TechniquePharmacotherapyCoronary Artery DiseaseAcute Myocardial InfarctionThrombosis	1988	694
The Relation of Risk Factors to the Development of Atherosclerosis in Saphenous-Vein Bypass Grafts and the Progression of Disease in the Native Circulation Lucien Campeau, M Enjalbert, Jacques Lespérance, New England Journal of Medicine	1984	625
Probucol and Multivitamins in the Prevention of Restenosis after Coronary Angioplasty Jean‐Claude Tardif, Gilles Côté, Jacques Lespérance, New England Journal of Medicine	1997	567
Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Claude M. Grondin, Lucien Campeau, Jacques Lespérance, PubMed Late ChangesConsecutive SeriesSv GraftsCardiovascular DiseaseEndovascular Technique	1984	525
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. David D. Waters, Lyall Higginson, Peter Gladstone, Circulation	1994	505
Clinical, angiographic, and hemodynamic findings in patients with anomalous origin of the coronary arteries. Bernard Chaitman, Jacques Lespérance, J Saltiel, Circulation Vascular DiseaseAnomalous OriginBenign AnomalyCoronary Artery DiseaseVascular Imaging	1976	436
Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Lucien Campeau, M Enjalbert, Jacques Lespérance, PubMed Sequential Angiographic StudiesHypertensionVascular DiseaseEndovascular TechniqueSurgery	1983	434
A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. David D. Waters, Jacques Lespérance, Marilyn Francetich, Circulation HypertensionCardiovascular PharmacologyPlacebo PatientsCoronary Artery DiseaseAcute Myocardial Infarction	1990	354
Discrepancies Between Cineangiographic and Postmortem Findings in Patients with Coronary Artery Disease and Recent Myocardial Revascularization Claude M. Grondin, Ihor Dyrda, A Pasternac, Circulation Coronary Artery GraftingSurgeryCoronary Artery DiseaseAcute Myocardial InfarctionConsecutive Patients	1974	341
Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions Jean‐Claude Tardif, Jean Grégoire, Philippe L. L’Allier, Circulation	2004	288

Page 1